Search
Stevaladil
go.drugbank.com/drugs/DB20689ExperimentalThe usage of the INN stem '-dil' in the name indicates that Stevaladil is a vasodilator. Stevaladil has a monoisotopic molecular weight of 447.33 Da.
Meluadrine
go.drugbank.com/drugs/DB20693ExperimentalThe usage of the INN stem '-drine' in the name indicates that Meluadrine is a sympathomimetic. Meluadrine has a monoisotopic molecular weight of 243.1 Da.
Bamirastine
go.drugbank.com/drugs/DB21186ExperimentalThe usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.
Barmastine
go.drugbank.com/drugs/DB21253ExperimentalThe usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.
Zanoterone
go.drugbank.com/drugs/DB21384ExperimentalThe usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.
Elunonavir
go.drugbank.com/drugs/DB21518ExperimentalThe usage of the INN stem '-vir' in the name indicates that Elunonavir is a antiviral. Elunonavir has a monoisotopic molecular weight of 1155.44 Da.
Telratolimod
go.drugbank.com/drugs/DB19590InvestigationalTelratolimod has a monoisotopic molecular weight of 593.47 Da. … Telratolimod is under investigation in clinical trial NCT06680479 (Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy
Rezivertinib
go.drugbank.com/drugs/DB21471InvestigationalRezivertinib has a monoisotopic molecular weight of 486.24 Da. … Rezivertinib is under investigation in clinical trial NCT06955325 (Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations).
Tuxobertinib
go.drugbank.com/drugs/DB21508InvestigationalTuxobertinib has a monoisotopic molecular weight of 560.19 Da. … Tuxobertinib is under investigation in clinical trial NCT04209465 (A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.).
Ibopamine
go.drugbank.com/drugs/DB13316ExperimentalCategories: Dopamine D1 Receptor Agonists, Compounds used in a research, industrial, or household setting